4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-24-003742
Chief Executive Officer sold 29,202 shares at an average $0.85 ($24,734)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2024-01-11 | Sale | −11,945 | $0.84 | $9,994 | 18,395 | D |
| Rawcliffe Adrian Chief Executive Officer | 2024-01-12 | Sale | −17,257 | $0.85 | $14,739 | 26,388 | D |
| Open-market sales · 29,202 sh · avg $0.85 · $24,734 | |||||||
Loading xslF345X05/tm243270-1_4seq1.xml…